Grown Rogue International (GRIN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
20 Aug, 2025Executive summary
Third quarter 2024 revenue rose 7% year-over-year to $7.0M, reflecting growth despite modest price compression in core markets.
Operating cash flow before working capital changes declined 24% to $1.2M, mainly due to increased SG&A for New Jersey expansion and one-time compensation.
Free cash flow was negative $1.2M, impacted by $2.2M in cash advances for New Jersey facility construction.
Phase I operations commenced in New Jersey, with first harvest completed and initial product drops expected in Q4 2024.
Expansion efforts continue in New Jersey and Illinois, with Phase II in NJ expected to complete in H1 2025 and Illinois Phase I targeted for H2 2025.
Financial highlights
Adjusted EBITDA (aEBITDA) remained flat at $2.1M year-over-year, with aEBITDA margin declining to 30.0% from 32.1%.
Gross profit for Q3 2024 was $3.9M, down from $4.4M in the prior year period.
Net loss for the quarter was $0.67M, compared to a net loss of $2.0M in the same quarter last year.
Cash and cash equivalents at quarter-end were $5.6M, down from $6.8M at the start of the year.
Outlook and guidance
Anticipates meaningful cash flow generation from New Jersey operations as market conditions evolve.
Expects Phase II of New Jersey facility to be completed in H1 2025, increasing production capacity to 1,100 pounds per month.
Illinois expansion is progressing, with Phase I completion targeted for H2 2025.
Management remains focused on disciplined, capital-efficient growth and is evaluating additional market opportunities.
Latest events from Grown Rogue International
- Returned to profitability with $2.5M net income, positive cash flow, and ongoing expansion.GRIN
Q2 202523 Nov 2025 - Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025